SMMT vs. ADMA
SMMT (Summit Therapeutics Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, SMMT returned 5.97%/yr vs 2.15%/yr for ADMA. At a 0.15 correlation, their price movements are largely independent.
Performance
SMMT vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMMT achieves a -18.35% return, which is significantly higher than ADMA's -53.02% return. Over the past 10 years, SMMT has outperformed ADMA with an annualized return of 5.97%, while ADMA has yielded a comparatively lower 2.15% annualized return.
SMMT
- 1D
- 3.85%
- 1M
- -14.08%
- YTD
- -18.35%
- 6M
- -21.32%
- 1Y
- -30.54%
- 3Y*
- 75.32%
- 5Y*
- 17.16%
- 10Y*
- 5.97%
ADMA
- 1D
- 3.13%
- 1M
- 4.00%
- YTD
- -53.02%
- 6M
- -56.89%
- 1Y
- -51.69%
- 3Y*
- 30.34%
- 5Y*
- 38.86%
- 10Y*
- 2.15%
SMMT vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -18.35% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
ADMA ADMA Biologics, Inc. | -53.02% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
Correlation
The correlation between SMMT and ADMA is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2015 | 0.15 |
Fundamentals
SMMT:
$11.07B
ADMA:
$2.06B
SMMT:
-$1.60
ADMA:
$0.68
SMMT:
20.28
ADMA:
5.27
SMMT:
$0.00
ADMA:
$509.86M
SMMT:
-$83.36K
ADMA:
$312.42M
SMMT:
-$738.34M
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. ADMA — Risk / Return Rank
SMMT
ADMA
SMMT vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMMT | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.55 | ||
| Sortino ratioReturn per unit of downside risk | +1.19 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 0.82 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.55 | -0.83 | +0.27 |
| Martin ratioReturn relative to average drawdown | -0.86 | -1.66 | +0.80 |
Loading charts...
Drawdowns
SMMT vs. ADMA - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum ADMA drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for SMMT and ADMA.
Loading charts...
Drawdown Indicators
| SMMT | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -91.28% | -4.47% |
Max Drawdown (1Y)Largest decline over 1 year | -55.49% | -62.71% | +7.22% |
Max Drawdown (3Y)Largest decline over 3 years | -64.44% | -68.99% | +4.55% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | -68.99% | -22.79% |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | -86.11% | -9.64% |
Current DrawdownCurrent decline from peak | -61.09% | -65.03% | +3.94% |
Average DrawdownAverage peak-to-trough decline | -57.63% | -53.07% | -4.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.70% | 31.23% | +4.47% |
Volatility
SMMT vs. ADMA - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 19.19% compared to ADMA Biologics, Inc. (ADMA) at 10.25%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.19% | 10.25% | +8.94% |
Volatility (6M)Calculated over the trailing 6-month period | 56.82% | 45.72% | +11.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.80% | 54.23% | +21.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.23% | 59.49% | +125.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.54% | 69.07% | +75.47% |
Dividends
SMMT vs. ADMA - Dividend Comparison
Neither SMMT nor ADMA has paid dividends to shareholders.
Financials
SMMT vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between Summit Therapeutics Inc. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SMMT and ADMA have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (19.19%) compared to ADMA (10.25%). In terms of maximum drawdown, SMMT dropped -95.75% vs ADMA's -91.28%.
SMMT currently has the higher Sharpe Ratio (-0.41 vs -0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMMT and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer